Angiotensin receptor blockers in heart failure after the ELITE II trial

about

Angiotensin receptor blockers in heart failure after the ELITE II trial

Item

http://www.wikidata.org/entity/Q24792591

description

2000 nî lūn-bûn

@nan

2000 թուականին հրատարակուած գիտական յօդուած

@hyw

2000 թվականին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Angiotensin receptor blockers in heart failure after the ELITE II trial

@ast

Angiotensin receptor blockers in heart failure after the ELITE II trial

@en

Angiotensin receptor blockers in heart failure after the ELITE II trial

@nl

type

Item

label

Angiotensin receptor blockers in heart failure after the ELITE II trial

@ast

Angiotensin receptor blockers in heart failure after the ELITE II trial

@en

Angiotensin receptor blockers in heart failure after the ELITE II trial

@nl

prefLabel

Angiotensin receptor blockers in heart failure after the ELITE II trial

@ast

Angiotensin receptor blockers in heart failure after the ELITE II trial

@en

Angiotensin receptor blockers in heart failure after the ELITE II trial

@nl

P1476

Angiotensin receptor blockers in heart failure after the ELITE II trial

@en

P2860

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group.

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial.

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.

P2888

cvm-1-2-079

P304

79-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CVM-1-2-079

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronnie Willenheimer

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11641719

http://www.w3.org/2001/XMLSchema#string

P6179

1013124567

http://www.w3.org/2001/XMLSchema#string

P698

11714415

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

59604

http://www.w3.org/2001/XMLSchema#string